| 摘要 |
<p>Therapeutic and/or diagnostic formulations intended to improve glucose uptake and the oxidation of nutrients in warm-blooded animals, including humans, presenting with cancer, in a manner that diminishes toxic by-products generated by these metabolic events, may be administered either for single daily independent administration or a binary morning and nighttime administration which also promotes sleep. In a preferred embodiment of the present invention, effective amounts of thiol-containing alkyl fatty acids, such as but not limited to those of lipoic acid and analogs thereof, are co-formulated with effective amounts of naturally- occurring or synthetic antioxidants, trace elements, plant extracts, carbohydrates, and other substances. Pharmaceutically-acceptable carriers and excipients may be included in the formulation as necessary.</p> |
